Background : Patients with unprovoked VTE have high recurrence risk if anticoagulation is stopped after initial treatment. How to determine the need for long- term anticoagulation is unclear. D- dimer results have been proposed as a risk stratification tool, with low values suggesting lower risk of recurrence. Aims : To evaluate risk of recurrent VTE in patients with first unprovoked proximal DVT or PE and negative D- dimer test on anticoagulants and 1 month after stopping. Methods : After 3 to 7 months of anticoagulation, 410 patients had D- dimer levels on and at 1 month off anticoagulation. If both were negative patients remained off anticoagulation and were followed for median of 5.0 years; longest duration of follow up 7.5 years. Prima...
none13Background The optimal duration of oral anticoagulation in patients with idiopathic venous th...
Patients with venous thromboembolism (VTE) secondary to transient risk factors may develop VTE recur...
Male patients, especially the young, are at a higher risk of recurrent venous thromboembolism (RVTE)...
The optimal duration of anticoagulation after recurrent venous thromboembolism(VTE) is poorly establ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
Background: The optimal duration of anticoagulation for a first episode of unprovoked venous thrombo...
Background: The optimal duration of anticoagulation for a first episode of unprovoked venous thromb...
The PROLONG randomized trial showed that a normal D-dimer (D-d) 1 month after anticoagulation suspen...
BACKGROUND: The optimal duration of oral anticoagulation in patients with idiopathic venous thromboe...
In some patients with previous venous thromboembolism (VTE) D-dimer levels (D-Dimer) tend to increas...
Background: Patients with venous thromboembolism (VTE) secondary to transient risk factors may devel...
BACKGROUND: The PROLONG randomized study showed that patients with an abnormal D-dimer after anticoa...
none13Background The optimal duration of oral anticoagulation in patients with idiopathic venous th...
Patients with venous thromboembolism (VTE) secondary to transient risk factors may develop VTE recur...
Male patients, especially the young, are at a higher risk of recurrent venous thromboembolism (RVTE)...
The optimal duration of anticoagulation after recurrent venous thromboembolism(VTE) is poorly establ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
The optimal duration of anticoagulation in patients with venous thromboembolism (VTE) is uncertain. ...
Background: The optimal duration of anticoagulation for a first episode of unprovoked venous thrombo...
Background: The optimal duration of anticoagulation for a first episode of unprovoked venous thromb...
The PROLONG randomized trial showed that a normal D-dimer (D-d) 1 month after anticoagulation suspen...
BACKGROUND: The optimal duration of oral anticoagulation in patients with idiopathic venous thromboe...
In some patients with previous venous thromboembolism (VTE) D-dimer levels (D-Dimer) tend to increas...
Background: Patients with venous thromboembolism (VTE) secondary to transient risk factors may devel...
BACKGROUND: The PROLONG randomized study showed that patients with an abnormal D-dimer after anticoa...
none13Background The optimal duration of oral anticoagulation in patients with idiopathic venous th...
Patients with venous thromboembolism (VTE) secondary to transient risk factors may develop VTE recur...
Male patients, especially the young, are at a higher risk of recurrent venous thromboembolism (RVTE)...